Nutritional management for children with solid tumors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to establish a standardized nutritional intervention for pediatric patients diagnosed with solid tumors. It involves a nutrition support team that includes dietitians, nutritionists, clinicians, and nursing staff to provide tailored nutritional management. The effectiveness of this intervention, including short peptide-based enteral nutrition, will be evaluated to improve the nutritional status of these children. Data on dietary intake, nutritional status, and clinical outcomes will be collected throughout the study.

Why it matters

Who can join: the full rules

1. Male and female, age 0-18 years old
2. Pathological diagnosis is malignant solid tumor with untreated initial onset

Where it's running

• Children's Hospital of Fudan University
  Shanghai, Shanghai Municipality, China Recruiting

Study contacts

• Study coordinator: Tian Qian, PhD
• Email: drqiantian@fudan.edu.cn
• Phone: 021-64931913

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Olive leaf extract plus endurance training to boost muscle performance in healthy adults

  This study tests whether taking olive leaf extract while doing endurance training helps healthy adults improve their exercise performance more than training with a placebo.

  Recruiting University of Lausanne · Lausanne · NCT07729072

• Carbon nanoparticle‑loaded iron for advanced solid tumors

  This test uses direct injections of a carbon nanoparticle‑loaded iron medicine (CNSI‑Fe) to see if it can shrink tumors in adults with advanced solid cancers who have no effective standard treatment options.

  Recruiting at 4 sites Phase 1/2 Sichuan Enray Pharmaceutical Sciences Company · Beijing, Beijing Municipality and 8 other locations · NCT07433283

• RGL-270 vaccine alone or with adebelimab to lower risk of cancer coming back after surgery

  This phase I trial will test whether a personalized mRNA vaccine called RGL-270, given alone or with the immune drug adebelimab, can help prevent recurrence in adults who had radical treatment for high‑risk malignant solid tumors.

  Recruiting Phase 1 Fudan University · Shanghai · NCT07348042

• Post-surgery nutrition shake to help recovery in older adults

  We will try a daily nutritional shake after surgery to see if it helps people 70 and older recover their strength and thinking compared with standard postoperative nutrition instructions.

  Recruiting Dartmouth-Hitchcock Medical Center · Lebanon, New Hampshire · NCT07109505

• Evaluating XNW29016 Tablets for Advanced Solid Tumors After Standard Treatment Failure

  This study is testing if XNW29016 tablets can help people with advanced solid tumors who haven't responded to regular treatments.

  Recruiting Phase 1/2 Evopoint Biosciences Inc. · Beijing, Beijing Municipality · NCT06987500

• Evaluating AD1208 for advanced solid tumors

  This study is testing a new drug called AD1208 to see if it is safe and tolerable for people with advanced solid tumors.

  Recruiting at 3 sites Phase 1/2 Avelos Therapeutics Inc. · Seongnam-si, Gyeonggi-do and 2 other locations · NCT06911333

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.